ALLAN ALDRICH OCAMPO: Open Payments
NPI 1245749738 · DUNKIRK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,628 in 135 payments from 15 companies in 2025. Trend: 2023 $883 · 2024 $1,746 · 2025 $2,628
Food & beverage: $2,628
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $507 |
| Otsuka America Pharmaceutical, Inc. | 28 | $458 |
| Alkermes, Inc. | 12 | $377 |
| Axsome Therapeutics, Inc. | 13 | $313 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $247 |
| Teva Pharmaceuticals USA, Inc. | 22 | $236 |
| ABBVIE INC. | 10 | $169 |
| Neurocrine BioSciences, Inc. | 3 | $119 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: FANAPT, Auvelity, CAPLYTA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.
Industry payments across NY — which companies pay providers there.
